QCI Interpret for Oncology

Clinician’s Roundtable: Interpreting genomic test results for precision oncology

May 21, 2024
You’re invited to attend the 2024 Clinician’s Roundtable, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for cancer patients. As the role of the Molecular Tumor Board (MTB) becomes increasingly important in the implementation of evidence-based precision cancer medicine programs, molecular pathology labs must overcome challenges in genomic test interpretation to ensure maximum clinical utility of molecular profiling results.

At this event, hear from clinicians at leading universities and organizations as they present real-world case studies of how molecular pathology labs can improve test turnaround, standardize test interpretation, and deliver comprehensive genomic reports with personalized diagnostic, prognostic, and therapeutic information for each patient.

The free-to-attend virtual event will consist of four educational parts:

1. Case Presentations: Clinicians from Dana Farber Cancer Institute and the National Cancer Institute will present cases of how their labs have overcome challenges in genomic test interpretation.

2. Live Q&A Session: Attendees will have the opportunity to ask the clinicians questions about their experiences implementing precision oncology programs at their institutions.

3. Solution Showcase: In a brief presentation, experts from QIAGEN Digital Insights will showcase our leading Sample to Insight solutions for molecular tumor profiling.

4. Future Forecast: The event will conclude with a short presentation about how molecular tumor profiling will change in the next five years and how labs can leverage new technologies to improve patient care.

Related videos

QCI Interpret for Oncology

QCI Interpret One: Oncology variant interpretation just got more precise

1,023 views June 12, 2020

Competing to offer a comprehensive genomic profiling service for solid or...

QCI Interpret for Oncology

Precision medicine for any cancer assay on any platform

1,017 views May 29, 2019

For NGS cancer testing, keeping pace with new discoveries is a serious...

QCI Interpret for Oncology

Managing multiple biomarker therapeutic development

405 views September 12, 2019

For the past two decades, the paradigm in the field has been “one biomarker,...

QCI Interpret for Oncology

FASTQ to final report: Ultra-fast workflow for CGP

371 views July 21, 2022

As our molecular knowledge of cancer continually evolves, a new era in cancer...